Anika Therapeutics (ANIK) Interest & Investment Income (2010 - 2026)
Anika Therapeutics' (ANIK) quarterly Interest & Investment Income came in at $426000.0 in Q2 2026, up 99.07% year-over-year from $214000.0 in Q2 2025, and down 36.13% quarter-over-quarter from $667000.0 in Q1 2026.
Powered by 
Analysis
Anika Therapeutics (ANIK) Interest & Investment Income (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Interest & Investment Income for 17 consecutive years, with $426000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 99.07% year-over-year to $426000.0 in Q2 2026; TTM through Jun 2026 was $2.2 million, a 24.11% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, down 25.37% from the prior year.
- Interest & Investment Income was $426000.0 for Q2 2026 at Anika Therapeutics, down from $667000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $997000.0 in Q3 2025 and troughed at -$154000.0 in Q1 2022.
- A 5-year average of $452222.2 and a median of $487500.0 in 2022 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 1008.33% in 2022, down 258.14% in 2022.
- Over 5 years, Interest & Investment Income stood at $276000.0 in 2022, then surged by 109.06% to $577000.0 in 2023, then rose by 28.94% to $744000.0 in 2024, then slumped by 84.14% to $118000.0 in 2025, then jumped by 261.02% to $426000.0 in 2026.
- The last three Interest & Investment Income figures came in at $426000.0 (Q2 2026), $667000.0 (Q1 2026), and $118000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | - |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | - |
| 10 | Anika Therapeutics | 279.40 Mn | 240.98 Mn | 21.24 Mn | 426,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 426,000.00 |
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Sep 30, 2025 | 997,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Mar 31, 2025 | 415,000.00 |
| Dec 31, 2024 | 744,000.00 |
| Sep 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 595,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | 577,000.00 |
| Sep 30, 2023 | 635,000.00 |
| Jun 30, 2023 | 561,000.00 |
| Mar 31, 2023 | 539,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 96,000.00 |
| Mar 31, 2022 | -154,000.00 |
| Dec 31, 2021 | -47,000.00 |
| Sep 30, 2021 | -48,000.00 |